Variant report

Variant	nsv869799
Chromosome Location	chr6:154187-209457
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1337)
CpG islands
(count:244)
Chromatin interactive
region (count:42)
LncRNA
region (count:26)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1337 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:168940-169157	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:157406-157408	K562	blood:	n/a	n/a
3	ATF2	chr6:193111-194543	GM12878	blood:	n/a	n/a
4	ATF2	chr6:181000-181701	GM12878	blood:	n/a	n/a
5	ATF2	chr6:181047-181898	GM12878	blood:	n/a	n/a
6	ATF2	chr6:188600-190870	GM12878	blood:	n/a	n/a
7	ATF2	chr6:154275-155106	GM12878	blood:	n/a	n/a
8	ATF2	chr6:156670-157032	GM12878	blood:	n/a	n/a
9	ATF2	chr6:209433-210258	GM12878	blood:	n/a	n/a
10	ATF2	chr6:188713-190294	GM12878	blood:	n/a	n/a
11	ATF2	chr6:154306-155179	GM12878	blood:	n/a	n/a
12	ATF2	chr6:193250-194551	GM12878	blood:	n/a	n/a
13	BACH1	chr6:209349-209668	H1-hESC	embryonic stem cell:	n/a	n/a
14	BATF	chr6:189313-189787	GM12878	blood:	n/a	n/a
15	BATF	chr6:183781-184092	GM12878	blood:	n/a	n/a
16	BATF	chr6:181382-181622	GM12878	blood:	n/a	n/a
17	BATF	chr6:154197-154629	GM12878	blood:	n/a	n/a
18	BATF	chr6:156491-157009	GM12878	blood:	n/a	n/a
19	BATF	chr6:188701-189864	GM12878	blood:	n/a	chr6:189809-189818
20	BATF	chr6:181320-181669	GM12878	blood:	n/a	n/a
21	BATF	chr6:193685-194335	GM12878	blood:	n/a	n/a
22	BATF	chr6:154691-155030	GM12878	blood:	n/a	n/a
23	BATF	chr6:154252-155133	GM12878	blood:	n/a	n/a
24	BATF	chr6:156683-156991	GM12878	blood:	n/a	n/a
25	BCL11A	chr6:156702-156991	GM12878	blood:	n/a	n/a
26	BCL11A	chr6:193667-194343	GM12878	blood:	n/a	n/a
27	BCL11A	chr6:156633-157058	GM12878	blood:	n/a	n/a
28	BCL11A	chr6:189370-189693	GM12878	blood:	n/a	n/a
29	BCL11A	chr6:154309-155065	GM12878	blood:	n/a	n/a
30	BCL11A	chr6:189288-190044	GM12878	blood:	n/a	n/a
31	BCL11A	chr6:181394-181586	GM12878	blood:	n/a	chr6:181481-181490
32	BCL3	chr6:193067-194409	GM12878	blood:	n/a	n/a
33	BCL3	chr6:154271-155009	GM12878	blood:	n/a	n/a
34	BCL3	chr6:155810-156195	GM12878	blood:	n/a	n/a
35	BCL3	chr6:203677-203927	GM12878	blood:	n/a	n/a
36	BCL3	chr6:188736-190047	GM12878	blood:	n/a	n/a
37	BCL3	chr6:189188-189736	GM12878	blood:	n/a	n/a
38	BCL3	chr6:203600-204033	GM12878	blood:	n/a	n/a
39	BCL3	chr6:181242-181640	GM12878	blood:	n/a	chr6:181481-181490
40	BCL3	chr6:194683-195018	GM12878	blood:	n/a	n/a
41	BCL3	chr6:154627-155012	GM12878	blood:	n/a	n/a
42	BCL3	chr6:193087-193559	GM12878	blood:	n/a	n/a
43	BCL3	chr6:193640-194390	GM12878	blood:	n/a	n/a
44	BCLAF1	chr6:188619-190372	GM12878	blood:	n/a	n/a
45	BCLAF1	chr6:181165-181751	GM12878	blood:	n/a	chr6:181481-181490
46	BCLAF1	chr6:193619-194351	GM12878	blood:	n/a	n/a
47	BCLAF1	chr6:188679-190442	GM12878	blood:	n/a	n/a
48	BCLAF1	chr6:193289-194435	GM12878	blood:	n/a	n/a
49	BCLAF1	chr6:154574-155179	GM12878	blood:	n/a	n/a
50	BHLHE40	chr6:188793-189712	GM12878	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:202452-202502	GM12892	blood:	n/a
2	chr6:179456-179506	AG10803	skin:	n/a
3	chr6:186671-186721	HepG2	liver:	n/a
4	chr6:186671-186721	GM12878	blood:	n/a
5	chr6:202452-202502	HRPEpiC	eye:	n/a
6	chr6:179456-179506	AG09309	skin:	n/a
7	chr6:179659-179709	RPTEC	kidney:	n/a
8	chr6:186671-186721	HUVEC	blood vessel:	n/a
9	chr6:186671-186721	HRE	kidney:	n/a
10	chr6:202452-202502	MCF10A-Er-Src	breast:	n/a
11	chr6:202452-202502	HMEC	breast:	n/a
12	chr6:186671-186721	SKMC	muscle:	n/a
13	chr6:186671-186721	AG04450	lung:	fetal
14	chr6:179456-179506	HCPEpiC	choroid plexus:	n/a
15	chr6:179456-179506	GM12891	blood:	n/a
16	chr6:186671-186721	NHDF-neo	bronchial:	n/a
17	chr6:179456-179506	Jurkat	blood:	n/a
18	chr6:179659-179709	NT2-D1	testis:	n/a
19	chr6:179456-179506	BJ	skin:	n/a
20	chr6:202452-202502	U87	brain:	n/a
21	chr6:179659-179709	GM06990	blood:	n/a
22	chr6:179659-179709	HepG2	liver:	n/a
23	chr6:179659-179709	LNCaP	prostate:	n/a
24	chr6:179659-179709	HAEpiC	amniotic membrane:	n/a
25	chr6:186671-186721	HPAEpiC	pulmonary alveolar:	n/a
26	chr6:186671-186721	AG10803	skin:	n/a
27	chr6:186671-186721	PFSK-1	brain:	n/a
28	chr6:179659-179709	SK-N-MC	brain:	n/a
29	chr6:186671-186721	T-47D	breast:	n/a
30	chr6:186671-186721	GM12891	blood:	n/a
31	chr6:186671-186721	HL-60	blood:	n/a
32	chr6:179659-179709	HCF	heart:	n/a
33	chr6:186671-186721	GM12892	blood:	n/a
34	chr6:202452-202502	PFSK-1	brain:	n/a
35	chr6:179659-179709	HRCEpiC	kidney:	n/a
36	chr6:179456-179506	HNPCEpiC	eye:	n/a
37	chr6:179456-179506	HIPEpiC	eye:	n/a
38	chr6:179456-179506	GM12892	blood:	n/a
39	chr6:179659-179709	AG04449	skin:	fetal
40	chr6:202452-202502	GM12891	blood:	n/a
41	chr6:202452-202502	HepG2	liver:	n/a
42	chr6:179659-179709	BE2_C	brain:	n/a
43	chr6:202452-202502	GM12878	blood:	n/a
44	chr6:179456-179506	HPAEpiC	pulmonary alveolar:	n/a
45	chr6:179456-179506	H1-hESC	embryonic stem cell:	embryo
46	chr6:186671-186721	AG09309	skin:	n/a
47	chr6:179456-179506	NH-A	brain:	n/a
48	chr6:179456-179506	HMEC	breast:	n/a
49	chr6:179456-179506	NHBE	bronchial:	n/a
50	chr6:202452-202502	Caco-2	colon:	n/a

(count:42 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:181320..184707-chr6:184919..187235,3	K562	blood:
2	chr6:188509..189446-chr6:686215..686918,2	MCF-7	breast:
3	chr6:188501..189288-chr6:558016..558846,2	MCF-7	breast:
4	chr6:182386..184733-chr6:187298..189526,2	K562	blood:
5	chr4:29168..29759-chr6:156896..157405,3	MCF-7	breast:
6	chr6:188538..189926-chr6:408487..409481,6	MCF-7	breast:
7	chr6:182386..184733-chr6:187298..189526,2	K562	blood:
8	chr6:181320..184707-chr6:184919..187235,3	K562	blood:
9	chr6:188865..189410-chr6:351061..352002,2	MCF-7	breast:
10	chr6:188655..189690-chr6:579041..579935,3	MCF-7	breast:
11	chr6:181397..184733-chr6:185247..188798,3	K562	blood:
12	chr6:174671..177385-chr6:182024..184445,2	K562	blood:
13	chr6:181397..184733-chr6:185247..188798,3	K562	blood:
14	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
15	chr6:181476..184276-chr6:186622..188907,2	MCF-7	breast:
16	chr6:188851..189352-chr6:372580..373236,2	MCF-7	breast:
17	chr6:190038..192340-chr6:196174..199027,2	K562	blood:
18	chr6:187321..190676-chr6:193869..196032,3	K562	blood:
19	chr6:162155..164910-chr6:167837..169506,2	K562	blood:
20	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
21	chr6:188512..189290-chr6:408309..409342,5	K562	blood:
22	chr6:162155..164910-chr6:167837..169506,2	K562	blood:
23	chr6:193592..196624-chr6:199092..202281,3	K562	blood:
24	chr6:201924..204091-chr6:207759..211489,3	K562	blood:
25	chr6:188398..189398-chr6:1436667..1437648,2	MCF-7	breast:
26	chr6:190038..192340-chr6:196174..199027,2	K562	blood:
27	chr6:193592..196624-chr6:199092..202281,3	K562	blood:
28	chr6:196917..201263-chr6:202620..206119,4	K562	blood:
29	chr6:184999..187022-chr6:291843..294537,2	MCF-7	breast:
30	chr6:188184..189040-chr6:551172..552162,2	MCF-7	breast:
31	chr4:28899..29522-chr6:156896..157400,2	MCF-7	breast:
32	chr6:188615..189306-chr6:374006..374509,2	MCF-7	breast:
33	chr6:187321..190676-chr6:193869..196032,3	K562	blood:
34	chr6:188750..189642-chr6:786566..787558,2	MCF-7	breast:
35	chr6:188545..189282-chr6:373635..374544,3	MCF-7	breast:
36	chr6:190862..192633-chr6:194886..196390,2	MCF-7	breast:
37	chr6:190862..192633-chr6:194886..196390,2	MCF-7	breast:
38	chr6:189816..192061-chr6:402339..404478,2	K562	blood:
39	chr6:188540..189516-chr6:407870..409552,18	MCF-7	breast:
40	chr6:181476..184276-chr6:186622..188907,2	MCF-7	breast:
41	chr6:188817..189398-chr6:524504..525502,3	MCF-7	breast:
42	chr6:174671..177385-chr6:182024..184445,2	K562	blood:

(count:26 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EXOC2-6	chr6:189476-189649	ENSG00000263667.1
2	lnc-AL035696.1-6	chr6:171079-171400	NONHSAT105973
3	lnc-EXOC2-20	chr6:170352-170631	NONHSAT105971
4	lnc-EXOC2-6	chr6:204887-205484	ENSG00000263667.1
5	lnc-AL035696.1-6	chr6:169950-170088	NONHSAT105973
6	lnc-EXOC2-6	chr6:184593-184809	ENSG00000263667.1
7	lnc-EXOC2-20	chr6:169545-169753	NONHSAT105971
8	lnc-EXOC2-6	chr6:198165-198509	ENSG00000263667.1
9	lnc-EXOC2-18	chr6:196682-196974	NONHSAT105977
10	lnc-AL035696.1-2	chr6:184601-187741	XLOC_005117
11	lnc-AL035696.1-5	chr6:155135-155395	XLOC_005116
12	lnc-AL035696.1-2	chr6:183914-184371	XLOC_005117
13	lnc-AL035696.1-1	chr6:203313-204413	ENSG00000205653.1
14	lnc-EXOC2-20	chr6:171827-172220	NONHSAT105972
15	lnc-AL035696.1-1	chr6:205487-206392	ENSG00000205653.1
16	lnc-EXOC2-6	chr6:186356-186561	ENSG00000263667.1
17	lnc-EXOC2-6	chr6:181466-181695	ENSG00000263667.1
18	lnc-EXOC2-20	chr6:168171-170561	NONHSAT105972
19	lnc-AL035696.1-6	chr6:170686-171068	NONHSAT105973
20	lnc-AL035696.1-2	chr6:184161-184371	NONHSAT105976
21	lnc-AL035696.1-5	chr6:156119-156514	XLOC_005116
22	lnc-AL035696.1-5	chr6:156546-156639	XLOC_005116
23	lnc-AL035696.1-2	chr6:186035-186494	NONHSAT105976
24	lnc-EXOC2-20	chr6:167607-167826	NONHSAT105971
25	lnc-EXOC2-6	chr6:187736-187906	ENSG00000263667.1
26	lnc-EXOC2-6	chr6:182366-182474	ENSG00000263667.1

No data

Variant related genes	Relation type
ENSG00000218577	TF binding region
ENSG00000263667	TF binding region
ENSG00000205653	TF binding region
ENSG00000218577	CpG island
ENSG00000263667	CpG island
ENSG00000205653	CpG island
ENSG00000263667	chromatin interactions
ENSG00000205653	chromatin interactions
ENSG00000112679	chromatin interactions
TRRAP	miRNA target sites
TSC1	miRNA target sites

Extended variants
information (count: 1105 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:1105 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116545216	chr6:154203-154204	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs375387669	chr6:154264-154265	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs369977314	chr6:154286-154287	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs375950986	chr6:154337-154338	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs372985589	chr6:154493-154494	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs114520107	chr6:154536-154537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs112464760	chr6:154567-154568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs113038791	chr6:154579-154580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs12524398	chr6:154694-154695	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs545744117	chr6:154738-154739	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs199991391	chr6:154749-154750	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs10484790	chr6:154750-154751	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs112970298	chr6:154788-154789	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs62388683	chr6:154801-154802	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs111545221	chr6:154846-154847	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs372936224	chr6:155212-155213	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
17	rs377224765	chr6:155432-155433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs148337345	chr6:155577-155578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs376960544	chr6:155578-155579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs554239991	chr6:155601-155602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs369981620	chr6:155685-155686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs115670676	chr6:155815-155816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs374495145	chr6:155941-155942	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs556551440	chr6:155975-155976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs35385584	chr6:156003-156004	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs542002353	chr6:156025-156026	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs555580085	chr6:156034-156035	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs562550261	chr6:156062-156063	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs572310529	chr6:156096-156097	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs116072078	chr6:156100-156101	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs371271036	chr6:156131-156132	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
32	rs531984318	chr6:156135-156136	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
33	rs372494423	chr6:156142-156143	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
34	rs377061905	chr6:156151-156152	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
35	rs531680063	chr6:156160-156161	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
36	rs565884913	chr6:156161-156162	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
37	rs113563289	chr6:156182-156183	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
38	rs369061401	chr6:156186-156187	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
39	rs541394626	chr6:156190-156191	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
40	rs371361984	chr6:156192-156193	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
41	rs376539712	chr6:156201-156202	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs41302901	chr6:156211-156212	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs377721708	chr6:156217-156218	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs371386809	chr6:156221-156222	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs570944175	chr6:156294-156295	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
46	rs200401345	chr6:156321-156322	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
47	rs373637098	chr6:156451-156452	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
48	rs371898365	chr6:156512-156513	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs367606315	chr6:156532-156533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs112862762	chr6:156669-156670	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Autism	22495311	CNVD
small cell lung cancer	20016488	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Prostate cancer	18632612	CNVD
Schizophrenia	20967226	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	20409316	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD

Chromatin state (count:386 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:149400-154200	Enhancers	GM12878-XiMat	blood
2	chr6:151800-155200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr6:151800-155600	Enhancers	HMEC	breast
4	chr6:153000-155000	Enhancers	NHEK	skin
5	chr6:153400-154800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr6:153600-154600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr6:153800-154200	Weak transcription	Thymus	Thymus
8	chr6:153800-154200	Enhancers	NHDF-Ad	bronchial
9	chr6:153800-157400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr6:154000-155800	Weak transcription	Fetal Thymus	thymus
11	chr6:154000-157000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr6:154200-154400	Enhancers	Placenta	Placenta
13	chr6:154200-154400	Enhancers	Thymus	Thymus
14	chr6:154200-154400	Flanking Active TSS	GM12878-XiMat	blood
15	chr6:154200-154600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr6:154200-155000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr6:154200-156200	Weak transcription	NHDF-Ad	bronchial
18	chr6:154400-154600	Enhancers	GM12878-XiMat	blood
19	chr6:154400-156200	Weak transcription	Thymus	Thymus
20	chr6:154600-155000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr6:154600-155200	Flanking Active TSS	GM12878-XiMat	blood
22	chr6:154600-155200	Enhancers	Osteobl	bone
23	chr6:154600-156200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr6:155000-155200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr6:155000-155200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
26	chr6:155000-155200	Enhancers	NHLF	lung
27	chr6:155200-156200	Weak transcription	NHLF	lung
28	chr6:155200-156400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr6:155200-156600	Weak transcription	Osteobl	bone
30	chr6:155200-157000	Enhancers	GM12878-XiMat	blood
31	chr6:155600-156000	Weak transcription	HMEC	breast
32	chr6:155600-158000	Enhancers	Adipose Nuclei	Adipose
33	chr6:155800-158000	Enhancers	Fetal Thymus	thymus
34	chr6:156000-156200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
35	chr6:156000-157600	Enhancers	HMEC	breast
36	chr6:156200-156400	Enhancers	Thymus	Thymus
37	chr6:156200-157000	Enhancers	NHLF	lung
38	chr6:156200-157200	Enhancers	NHDF-Ad	bronchial
39	chr6:156200-157400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr6:156400-156800	Weak transcription	Thymus	Thymus
41	chr6:156400-157000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr6:156800-157000	Enhancers	Osteobl	bone
43	chr6:156800-157600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
44	chr6:156800-157600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
45	chr6:156800-157600	Enhancers	Thymus	Thymus
46	chr6:157000-157200	Flanking Active TSS	GM12878-XiMat	blood
47	chr6:157200-157400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
48	chr6:157200-157400	Enhancers	GM12878-XiMat	blood
49	chr6:157400-157600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr6:157400-157600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links